Close Menu

consumer genomics

The Chinese government has implemented clearer regulatory guidance for genomic tests and invested in both clinical testing and research, spurring growth.

Growing interest in precision medicine is spurring genetic testing services claiming to personalize diets, but Janssens' research indicates the evidence is still lacking.

Following a successful pilot with 23andMe, the Healthy Nevada Project partners with Helix to increase the depth of genomics data while giving participants access to DNA results.

The Healthy Nevada Project will enroll an additional 40,000 participants to be exome sequenced through Helix and receive a free app from its online genomics marketplace.

The firm plans to offer genome, gut microbiome, and epigenome analyses and will collaborate with nutritional supplement developer and majority shareholder Thorne.

The newly launched LunaDNA hopes that its community model of compensating individuals for contributing genomic and health information will lead to better research.

EncrypGen will integrate its genetics blockchain solution into the Health Wizz consumer health app, and will sell Codigo46's genetic testing product through its website.

According to the Federal Register notice, after a first time FDA marketing authorization, manufacturers can commercialize new GHR tests without additional review.

23andMe said it plans to use the money raised to grow its customer base, expand its therapeutics group, and invest in its genetic research platform.

Earlier this week, the company launched Genomic Explorer in the US, a web-based service that enables consumers to upload their genomic data for viewing and analysis.

Pages

Following discrimination allegations, NICHD's Constantine Stratakis withdraws from a new position at the Research Institute of the McGill University Health Center, Science reports.

US President Donald Trump has threatened to cut World Health Organization funding over its pandemic response, which would affect its ability to do its work and which he might not be able to do.

The US Securities and Exchange Commission has halted the sales of a handful of stocks over claims made about the coronavirus.

In Nature this week: comparative analyses of single-cell RNA sequencing protocols uncover differences between approaches, and more.